Chinese blood products firm loses $9 billion value in just 10 days
China's Shanghai RAAS Blood Products, which manufactures and develops human blood products, has lost $9.2 billion in value in just 10 days. Its shares have plunged more than 60% in December. Shanghai RAAS, which said in 2015 that it would begin investing in stocks, accrued losses of $130 million in securities investments in the first nine months of this year.